• Crispr Therapeutics gains amid takeover speculation (CRSP:NASDAQ) Seeking Alpha Mon, 17 Nov 2025 16:12:24 GMT
• Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever Business Wire Mon, 17 Nov 2025 16:00:00 GMT
• 1 Underrated Stock That Could Soar by 58%, According to Wall Street The Motley Fool Mon, 17 Nov 2025 11:53:00 GMT
• New CRISPR Phase 1 trial hints at a first-of-its-kind heart treatment on horizon Drug Discovery News Mon, 17 Nov 2025 10:13:39 GMT
• Building trade automation scripts for CRISPR Therapeutics AG - Entry Point & High Conviction Trade Alerts newser.com Sun, 16 Nov 2025 18:04:52 GMT
• Gene Editing Therapy Slashes Cholesterol Levels in Half Dallas Express Sun, 16 Nov 2025 14:35:32 GMT
• (crsp) price dynamics and execution-aware positioning news.stocktradersdaily.com Sun, 16 Nov 2025 13:08:02 GMT
• crispr therapeutics ag stock trendline breakdown - weekly trade report & free safe capital growth stock tips newser.com Sat, 15 Nov 2025 23:24:38 GMT
• is crispr therapeutics ag 1cg a good long term investment - technical resistance breaks & affordable investment portfolio earlytimes.in Sat, 15 Nov 2025 12:38:46 GMT
• Is Now the Right Time for CRISPR Therapeutics After a 26.9% Pullback? simplywall.st Sat, 15 Nov 2025 06:17:50 GMT
• what to do if you’re stuck in crispr therapeutics ag - weekly investment summary & real-time market sentiment reports newser.com Fri, 14 Nov 2025 21:11:07 GMT
• crispr therapeutics call volume above normal and directionally bullish TipRanks Fri, 14 Nov 2025 20:13:15 GMT
• ai meets genetic agency at dyno gatc 2025 Genetic Engineering and Biotechnology News Fri, 14 Nov 2025 18:52:40 GMT
• has crispr therapeutics ag found a price floor - july 2025 intraday action & long-term safe investment plans newser.com Fri, 14 Nov 2025 18:29:50 GMT
• equities analysts issue forecasts for crsp fy2026 earnings MarketBeat Fri, 14 Nov 2025 17:06:25 GMT
• H.C. Wainwright Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating, Maintains Target Price $80 富途牛牛 Fri, 14 Nov 2025 16:05:58 GMT
• Research Analysts Set Expectations for CRSP FY2025 Earnings MarketBeat Fri, 14 Nov 2025 15:44:37 GMT
• FY2025 Earnings Estimate for CRSP Issued By Leerink Partnrs MarketBeat Fri, 14 Nov 2025 15:44:33 GMT
• clinical trial design and operations in genome editing therapeutics BioXconomy Fri, 14 Nov 2025 15:25:44 GMT
• how to build a dashboard for crispr therapeutics ag stock - weekly investment summary & free high return stock watch alerts newser.com Fri, 14 Nov 2025 15:05:19 GMT
• CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know Yahoo Finance Fri, 14 Nov 2025 14:00:02 GMT
• can ntla stock bounce back in 2026 after recent pipeline setbacks? TradingView Fri, 14 Nov 2025 13:58:00 GMT
• News: CMN Weekly (14 November 2025) - Your Weekly CRISPR Medicine News CRISPR Medicine News Fri, 14 Nov 2025 13:54:02 GMT
• why crispr therapeutics ag stock could rally in 2025 - 2025 support & resistance & fast entry momentum alerts newser.com Fri, 14 Nov 2025 13:23:35 GMT
• Is CRISPR Therapeutics AG stock a top pick in earnings season - Wall Street Watch & Risk Adjusted Buy and Sell Alerts Fundação Cultural do Pará Fri, 14 Nov 2025 13:02:01 GMT
• Inside the Human Gene Editing Boom Driven by CRISPR Reshaping Everything From Medicine to Food ZME Science Fri, 14 Nov 2025 09:11:02 GMT
• has crispr therapeutics ag found a price floor - 2025 price momentum & reliable volume spike trade alerts newser.com Fri, 14 Nov 2025 06:46:39 GMT
• is crispr therapeutics ag showing signs of accumulation - 2025 market wrapup & growth focused stock reports newser.com Fri, 14 Nov 2025 04:39:11 GMT
• what to expect from crispr therapeutics ag in the next 30 days - 2025 key highlights & smart money movement alerts newser.com Thu, 13 Nov 2025 21:15:22 GMT
• CRISPR Therapeutics Post Q3 Earnings: Testing Investor Patience, But Still A Buy (CRSP) Seeking Alpha Thu, 13 Nov 2025 20:43:39 GMT
• Q4 EPS Estimate for CRISPR Therapeutics Raised by Analyst MarketBeat Thu, 13 Nov 2025 14:46:34 GMT
• Citigroup Maintains CRISPR Therapeutics (CRSP) Buy Recommendation Nasdaq Thu, 13 Nov 2025 12:04:00 GMT
• 18,315 shares in crispr therapeutics ag $crsp purchased by nwam llc MarketBeat Thu, 13 Nov 2025 11:53:35 GMT
• Advyzon Investment Management LLC Invests $282,000 in CRISPR Therapeutics AG $CRSP MarketBeat Thu, 13 Nov 2025 08:23:01 GMT
• CRISPR Therapeutics (CRSP): Assessing Valuation Following Promising Early CTX310 Cardiovascular Trial Results simplywall.st Thu, 13 Nov 2025 05:40:51 GMT
• building trade automation scripts for crispr therapeutics ag - 2025 performance recap & technical pattern alert system newser.com Thu, 13 Nov 2025 03:47:34 GMT
• has crispr therapeutics ag found a price floor - earnings recap report & low risk profit maximizing plans newser.com Thu, 13 Nov 2025 02:11:22 GMT
• ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried? Nasdaq Wed, 12 Nov 2025 22:04:00 GMT
• FDA unveils new regulatory roadmap for bespoke drug therapies BioPharma Dive Wed, 12 Nov 2025 22:03:57 GMT
• crsp: citigroup lowers price target amid continued buy rating | GuruFocus Wed, 12 Nov 2025 21:36:20 GMT
• Equities Analysts Offer Predictions for CRSP FY2026 Earnings MarketBeat Wed, 12 Nov 2025 13:45:36 GMT
• Robert W. Baird Lowers CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $44.00 MarketBeat Wed, 12 Nov 2025 13:41:34 GMT
• RBC Capital Sticks to Its Hold Rating for Crispr Therapeutics AG (CRSP) The Globe and Mail Wed, 12 Nov 2025 13:34:10 GMT
• promising outlook for crispr therapeutics ag: buy rating backed by strong product launches and strategic developments TipRanks Wed, 12 Nov 2025 13:11:42 GMT
• is crispr therapeutics ag (1cg) stock a buy on weakness - quarterly growth report & stepwise trade signal guides newser.com Wed, 12 Nov 2025 05:45:06 GMT
• why retail investors favor crispr therapeutics ag stock - july 2025 decliners & long-term growth plans newser.com Wed, 12 Nov 2025 05:07:49 GMT
• Baird Maintains CRISPR Therapeutics (CRSP) Neutral Recommendation Nasdaq Tue, 11 Nov 2025 21:51:00 GMT
• crispr therapeutics (nasdaq:crsp) announces quarterly earnings results MarketBeat Tue, 11 Nov 2025 21:16:53 GMT
• CRISPR Therapeutics's Options Frenzy: What You Need to Know Benzinga Tue, 11 Nov 2025 20:02:14 GMT
• ‘Unprecedented’: Single dose of new gene-editing therapy lowers cholesterol, triglycerides Cardiovascular Business Tue, 11 Nov 2025 19:38:01 GMT
• Regeneron, CRISPR Therapeutics execs will represent biotech at Wednesday MAHA event Endpoints News Tue, 11 Nov 2025 19:12:00 GMT
• what to expect from crispr therapeutics ag in the next 30 days - trade entry summary & proven capital preservation methods newser.com Tue, 11 Nov 2025 18:43:32 GMT
• Can CRISPR Therapeutics' (CRSP) In Vivo Breakthrough Reshape Its Long-Term Cardiovascular Ambitions? simplywall.st Tue, 11 Nov 2025 17:28:50 GMT
• CRISPR Therapeutics (NASDAQ:CRSP) Price Target Lowered to $80.00 at Needham & Company LLC MarketBeat Tue, 11 Nov 2025 17:12:58 GMT
• rbc capital maintains crsp rating, ups price target to $50.00 | GuruFocus Tue, 11 Nov 2025 16:04:21 GMT
• Voyager, Transition Bio's small molecule drug pact; CRISPR Therapeutics ends work on a CAR-T therapy Endpoints News Tue, 11 Nov 2025 15:41:00 GMT
• crispr therapeutics is maintained at sector perform by rbc capital 富途牛牛 Tue, 11 Nov 2025 15:30:00 GMT
• crsp posts narrower-than-expected loss in q3, sales miss estimates Finviz Tue, 11 Nov 2025 15:18:33 GMT
• CRISPR Therapeutics' Investigational Gene Therapy Shows Promising Lipid-Lowering Effects In Early Trial Benzinga Tue, 11 Nov 2025 14:50:51 GMT
• Sickle Cell Disease Treatment Market Research Report 2025 Featuring Novartis, Pfizer, Bluebird Bio, GlycoMimetics, Emmaus Medical,... Yahoo Finance Tue, 11 Nov 2025 14:40:00 GMT
• crsp receives maintained neutral rating with lowered price target by baird | crsp stock news GuruFocus Tue, 11 Nov 2025 13:42:23 GMT
• truist financial maintains crispr therapeutics(crsp.us) with buy rating 富途牛牛 Tue, 11 Nov 2025 13:35:01 GMT
• analysts have conflicting sentiments on these healthcare companies: amn healthcare services (amn) and crispr therapeutics ag (crsp... The Globe and Mail Tue, 11 Nov 2025 13:26:00 GMT
• crispr therapeutics price target lowered to $44 from $52 at baird TipRanks Tue, 11 Nov 2025 12:52:40 GMT
• rbc raises price target on crispr therapeutics to $50 from $42, keeps sector perform, speculative risk MarketScreener Tue, 11 Nov 2025 11:50:57 GMT
• CRISPR Therapeutics (CRSP): Exploring Valuation After Recent 25% Share Price Decline Yahoo Finance Tue, 11 Nov 2025 11:13:18 GMT
• CRISPR Therapeutics stock holds Market Outperform rating as CTX310 shows promise Investing.com Tue, 11 Nov 2025 11:00:03 GMT
• baird lowers crispr therapeutics stock price target to $44 on pipeline concerns Investing.com India Tue, 11 Nov 2025 10:35:15 GMT
• CRISPR Therapeutics price target raised to $50 from $42 at RBC Capital Investing.com Tue, 11 Nov 2025 10:18:02 GMT
• crispr's mixed week: breakthrough heart health treatment and a patient death BioXconomy Tue, 11 Nov 2025 10:17:09 GMT
• CRISPR Therapeutics stock maintains Outperform rating at Oppenheimer Investing.com Tue, 11 Nov 2025 10:11:40 GMT
• crispr therapeutics' (crsp) drug shows promising lipid lowering results - citizens StreetInsider Tue, 11 Nov 2025 09:45:55 GMT
• crispr therapeutics (crsp) pt raised to $50 at rbc capital StreetInsider Tue, 11 Nov 2025 09:25:55 GMT
• oppenheimer reiterates outperform rating on crispr therapeutics (crsp) StreetInsider Tue, 11 Nov 2025 09:03:55 GMT
• Decoding CRISPR Therapeutics AG (CRSP): A Strategic SWOT Insight GuruFocus Tue, 11 Nov 2025 05:22:12 GMT
• crispr therapeutics ag: hold rating amid financial challenges and mixed pipeline progress TipRanks Tue, 11 Nov 2025 01:27:38 GMT
• CRISPR Therapeutics' Gene-Editing Drug Cuts LDL Cholesterol, Triglycerides in Early Human Trial Precision Medicine Online Mon, 10 Nov 2025 23:30:34 GMT
• crispr’s one-shot cholesterol killer: halving heart risks forever WebProNews Mon, 10 Nov 2025 23:01:08 GMT
• Why These Two Gene-Editing Stocks Just Diverged Investor's Business Daily Mon, 10 Nov 2025 21:58:00 GMT
• CRISPR Therapeutics stock price target lowered to $50 at Clear Street Investing.com Mon, 10 Nov 2025 21:21:34 GMT
• Reporter’s Notebook: Is Intellia’s Patient Death the Nail in the Coffin for Cas9? Inside Precision Medicine Mon, 10 Nov 2025 21:10:35 GMT
• needham maintains crispr therapeutics (crsp) buy recommendation Nasdaq Mon, 10 Nov 2025 20:56:00 GMT
• crispr therapeutics (crsp) pt lowered to $50 at clear street StreetInsider Mon, 10 Nov 2025 20:26:37 GMT
• intellia therapeutics, inc. securities lawsuit investigation Claim Depot Mon, 10 Nov 2025 20:09:48 GMT
• crsp's target price lowered by needham, maintains 'buy' rating | crsp stock news GuruFocus Mon, 10 Nov 2025 17:43:33 GMT
• #AHA25: CRISPR Therapeutics’ gene editing therapy halves cholesterol and triglycerides in early trial Endpoints News Mon, 10 Nov 2025 15:25:00 GMT
• crispr therapeutics ag reports earnings results for the third quarter and nine months ended september 30, 2025 MarketScreener Mon, 10 Nov 2025 15:21:37 GMT
• crispr therapeutics misses revenue target but holds analyst support Finimize Mon, 10 Nov 2025 14:24:19 GMT
• CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates Yahoo Finance Mon, 10 Nov 2025 14:10:02 GMT
• promising prospects for crispr therapeutics ag: ctx310’s breakthrough in cardiovascular care TipRanks Mon, 10 Nov 2025 14:05:03 GMT
• crsp advances gene editing with global trials and new innovations GuruFocus Mon, 10 Nov 2025 13:46:27 GMT
• crispr therapeutics widens net loss in q3, revenue rises MarketScreener Mon, 10 Nov 2025 13:32:44 GMT
• crispr therapeutics earnings beat by $0.09, revenue fell short of estimates Investing.com Mon, 10 Nov 2025 13:30:01 GMT
• crispr therapeutics reports q3 eps ($1.17), consensus ($1.29) TipRanks Mon, 10 Nov 2025 13:29:54 GMT
• CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results GlobeNewswire Mon, 10 Nov 2025 13:00:00 GMT
• CRISPR Therapeutics (NASDAQ: CRSP) notes CASGEVY: nearly 300 referrals, 39 infusions Stock Titan Mon, 10 Nov 2025 13:00:00 GMT
• h.c. wainwright maintains crispr therapeutics(crsp.us) with buy rating, maintains target price $80 富途牛牛 Mon, 10 Nov 2025 12:31:00 GMT
• what to expect from crispr therapeutics ag in the next 30 days - weekly investment report & free risk controlled daily trade plans... newser.com Mon, 10 Nov 2025 11:15:51 GMT
• crispr rises after experimental therapy cuts harmful cholesterol levels by half in small study TradingView Mon, 10 Nov 2025 11:15:30 GMT
• promising phase i results of ctx310 justify buy rating for crispr therapeutics TipRanks Mon, 10 Nov 2025 11:09:22 GMT
• moors & cabot inc. purchases new position in crispr therapeutics ag $crsp MarketBeat Mon, 10 Nov 2025 10:35:39 GMT
• promising efficacy of crispr therapeutics’ ctx310 in dyslipidemia treatment drives buy rating TipRanks Mon, 10 Nov 2025 09:52:29 GMT
• retail traders call crispr as 'undervalued' after trial success | tap to know more | inshorts Inshorts Mon, 10 Nov 2025 09:49:22 GMT
• CRISPR-Cas9 Gene Editing for Refractory Dyslipidemia Shows Safety and Preliminary Efficacy Cleveland Clinic Mon, 10 Nov 2025 09:22:30 GMT
• retail bulls call crispr ‘criminally undervalued’ after gene-editing breakthrough cuts cholesterol by 70% Stocktwits Mon, 10 Nov 2025 07:44:00 GMT
• crsp unveils promising phase 1 results for gene-editing therapy GuruFocus Sun, 09 Nov 2025 18:29:05 GMT
• crispr therapy shows large cholesterol and triglyceride reduction in phase 1 trial Pulse 2.0 Sun, 09 Nov 2025 14:25:36 GMT
• is crispr therapeutics ag stock a top pick in earnings season - 2025 support & resistance & growth focused investment plans newser.com Sun, 09 Nov 2025 14:16:14 GMT
• CRISPR Therapeutics Stock (CRSP) Opinions on CTX310 Phase 1 Data Release Quiver Quantitative Sun, 09 Nov 2025 14:04:00 GMT
• cholesterol slashed by 50%! revolutionary crispr gene editing therapy promises heart disease breakthrough Pune Mirror Sun, 09 Nov 2025 09:11:36 GMT
• crispr gene therapy slashes ‘bad’ cholesterol, triglycerides by half in small study The Straits Times Sun, 09 Nov 2025 06:28:15 GMT
• assessing crispr therapeutics stock after 24.6% drop and breakthrough gene editing news Yahoo Finance Sun, 09 Nov 2025 03:12:00 GMT
• one-time crispr therapy slashes cholesterol in human trial Evrim Ağacı Sun, 09 Nov 2025 01:25:50 GMT
• more drugs to fight high cholesterol are emerging The Wall Street Journal Sat, 08 Nov 2025 22:28:00 GMT
• crispr (crsp) reports promising phase 1 trial results for ctx310 GuruFocus Sat, 08 Nov 2025 18:02:25 GMT
• crispr updates early-stage trial data for heart disease therapy Seeking Alpha Sat, 08 Nov 2025 16:50:19 GMT
• gene therapy shows promise for cutting ldl in half in tough-to-treat dyslipidemia MedPage Today Sat, 08 Nov 2025 16:38:24 GMT
• crispr-based treatment cuts cholesterol and triglycerides in early study statnews.com Sat, 08 Nov 2025 15:00:29 GMT
• CRISPR Therapeutics Reports Positive Phase 1 Data for CTX310® Demonstrating Significant Lipid Reductions at AHA Scientific Session... Quiver Quantitative Sat, 08 Nov 2025 15:00:00 GMT
• cleveland clinic doctors say gene-editing therapy could revolutionize cholesterol treatment WKYC Sat, 08 Nov 2025 15:00:00 GMT
• CRISPR Therapeutics Announces Positive Phase 1 Clinical GlobeNewswire Sat, 08 Nov 2025 14:56:00 GMT
• CRISPR Therapeutics (Nasdaq: CRSP) announces 73% ANGPTL3 drop in Phase 1 CTX310 trial Stock Titan Sat, 08 Nov 2025 14:56:00 GMT
• harmful cholesterol levels cut in half with one-time gene editing drug in early trial NBC News Sat, 08 Nov 2025 14:56:00 GMT
• crispr gene therapy slashes 'bad' cholesterol, triglycerides by half in small study TradingView Sat, 08 Nov 2025 14:56:00 GMT
• Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides Cleveland Clinic Newsroom Sat, 08 Nov 2025 08:00:00 GMT
• CRISPR gene-editing works to reduce high cholesterol in a new study NPR Sat, 08 Nov 2025 08:00:00 GMT
• Assessing CRISPR Therapeutics Stock After 24.6% Drop and Breakthrough Gene Editing News Yahoo Finance Sat, 08 Nov 2025 08:00:00 GMT
• How a ‘one and done’ gene-editing treatment could lower cholesterol The Washington Post Sat, 08 Nov 2025 08:00:00 GMT
• CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia TCTMD.com Sat, 08 Nov 2025 08:00:00 GMT
• Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angio... Intellia Therapeutics Sat, 08 Nov 2025 08:00:00 GMT
• crispr therapeutics ag (crsp) stock drops despite market gains: important facts to note MSN Sat, 08 Nov 2025 00:08:24 GMT
• CRISPR Therapeutics AG (CRSP) Stock Drops Despite Market Gains: Important Facts to Note Nasdaq Fri, 07 Nov 2025 22:50:00 GMT
• intellia therapeutics patient death prompts fda clinical hold on crispr heart disease trials The Business Journals Fri, 07 Nov 2025 17:23:00 GMT
• intellia therapeutics’ stock rocked by patient death in gene therapy trial Clinical Trials Arena Fri, 07 Nov 2025 14:34:20 GMT
• crispr therapeutics (nasdaq:crsp) price target cut to $9.00 by analysts at wedbush MarketBeat Fri, 07 Nov 2025 14:33:18 GMT
CRISPR Therapeutics AG(NASDAQ:CRSP) 
CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases. The company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), a gene editing technolo...
Website: http://www.crisprtx.com
Founded: 1987
Full Time Employees: 458 (Dec 2022)
Sector: Healthcare
Industry: Biotechnology
